Christophe Baudouin Selected Research

HLA Antigens (Human Leukocyte Antigens)

6/2016	Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial.
10/2007	Th1 and Th2 responses on the ocular surface in uveitis identified by CCR4 and CCR5 conjunctival expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christophe Baudouin Research Topics

Disease

62	Dry Eye Syndromes (Dry Eye Syndrome) 02/2024 - 01/2002
42	Glaucoma 10/2023 - 10/2003
35	Inflammation (Inflammations) 10/2023 - 11/2002
13	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2023 - 11/2009
13	Ocular Hypertension (Glaucoma, Suspect) 01/2023 - 11/2009
12	Keratitis 12/2020 - 11/2002
10	Pain (Aches) 09/2022 - 01/2018
8	Cataract (Cataracts) 10/2023 - 02/2014
7	Blister (Bulla) 11/2022 - 11/2005
6	Hypersensitivity (Allergy) 10/2022 - 03/2004
5	Corneal Injuries 10/2021 - 07/2007
4	Infections 03/2022 - 05/2007
4	Hyperemia 01/2020 - 07/2005
3	Ulcer 01/2022 - 01/2018
3	Toxic Optic Neuropathy 04/2021 - 09/2007
3	Cystinosis 01/2021 - 03/2014
3	Ganglion Cysts (Ganglion) 01/2021 - 01/2016
3	Metaplasia 01/2017 - 07/2010
3	Photophobia (Light Sensitivity) 01/2017 - 05/2009
3	Wounds and Injuries (Trauma) 11/2012 - 03/2009
3	Uveitis 06/2008 - 10/2007
2	Edema (Dropsy) 03/2022 - 03/2009
2	Endophthalmitis (Ophthalmia) 01/2022 - 09/2020
2	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2021 - 01/2018
2	Hyperalgesia 12/2020 - 11/2020
2	Neuroinflammatory Diseases 01/2020 - 02/2016
2	Blindness (Hysterical Blindness) 01/2020 - 01/2017
2	Keratoconjunctivitis Sicca 01/2017 - 03/2004
2	Fibrosis (Cirrhosis) 09/2015 - 12/2012
2	Blepharitis 03/2015 - 01/2015
2	Meibomian Gland Dysfunction 01/2015 - 11/2013
2	Necrosis 02/2008 - 09/2007
1	Keratoconus 02/2023
1	Skin Diseases (Skin Disease) 10/2022

Drug/Important Bio-Agent (IBA)

30	Ophthalmic Solutions (Eye Drops)IBA 01/2023 - 11/2002
18	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2023 - 12/2003
16	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2023 - 01/2002
15	EmulsionsIBA 01/2024 - 08/2009
13	Latanoprost (Xalatan)FDA Link 01/2023 - 05/2004
12	HLA-DR Antigens (HLA-DR)IBA 01/2019 - 01/2002
8	Retinaldehyde (Retinal)IBA 03/2022 - 01/2012
7	Lubricant Eye Drops (Artificial Tears)IBA 01/2024 - 01/2017
7	Fluorescein (Funduscein)FDA LinkGeneric 01/2020 - 11/2002
6	CytokinesIBA 04/2018 - 12/2004
6	Antiglaucoma AgentsIBA 03/2014 - 10/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 11/2006
5	Hyaluronic Acid (Hyaluronan)IBA 11/2020 - 06/2005
5	ChemokinesIBA 04/2018 - 01/2008
4	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2023 - 07/2005
4	LipidsIBA 05/2020 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2017
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2012
4	Ammonium CompoundsIBA 01/2017 - 02/2008
3	Messenger RNA (mRNA)IBA 03/2022 - 04/2016
3	Cystine (L-Cystine)IBA 01/2021 - 03/2014
3	Cysteamine (Mercaptamine)FDA Link 01/2021 - 03/2014
3	SolutionsIBA 01/2021 - 11/2016
3	HCEIBA 05/2020 - 06/2011
3	Analgesics (Analgesic Drugs)IBA 12/2019 - 01/2018
3	LubricantsIBA 07/2019 - 03/2017
3	hydroxypropyl guarIBA 01/2018 - 01/2017
3	TrehaloseIBA 01/2017 - 01/2011
3	ProstaglandinsIBA 04/2016 - 07/2005
3	Timolol (Blocadren)FDA LinkGeneric 11/2009 - 05/2004
2	A-factor (Streptomyces)IBA 02/2023 - 07/2005
2	Fibronectins (Fibronectin)IBA 03/2022 - 02/2022
2	AntioxidantsIBA 02/2022 - 10/2018
2	Tolonium Chloride FDA Link 12/2020 - 05/2019
2	Detergents (Detergent)IBA 11/2020 - 12/2012
2	EnkephalinsIBA 02/2019 - 04/2018
2	MucinsIBA 01/2019 - 07/2008
2	AntigensIBA 01/2019 - 11/2011
2	Interleukin-8 (Interleukin 8)IBA 04/2018 - 12/2004
2	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 03/2017 - 01/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 06/2016 - 10/2007
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 09/2012 - 06/2005
2	OccludinIBA 09/2011 - 06/2011
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2008 - 11/2005
2	EndotoxinsIBA 06/2008 - 01/2008
2	Travoprost (Travatan)FDA Link 01/2008 - 09/2007
2	Chemokine ReceptorsIBA 01/2008 - 01/2008
2	LipopolysaccharidesIBA 07/2007 - 11/2006
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2023

Therapy/Procedure

15	Therapeutics 10/2023 - 11/2009
10	Filtering Surgery 11/2022 - 11/2002
5	Phacoemulsification 10/2023 - 03/2009
5	Contact Lenses 10/2022 - 10/2005
5	Slit Lamp 01/2022 - 12/2007
5	Trabeculectomy (Trabeculoplasty) 01/2019 - 11/2005
4	Refractive Surgical Procedures 07/2023 - 10/2005
4	Stents 09/2020 - 02/2014
2	Laser In Situ Keratomileusis (LASIK) 07/2023 - 04/2015
2	Semiconductor Lasers 09/2021 - 01/2021
2	Operative Surgical Procedures 09/2021 - 08/2021
2	Retreatment 08/2021 - 01/2021
2	Lasers (Laser) 08/2021 - 01/2021
2	Activities of Daily Living (ADL) 10/2020 - 11/2018
2	Drug Therapy (Chemotherapy) 05/2019 - 11/2002
2	Cautery 02/2016 - 09/2015
1	Percutaneous Collagen Induction 11/2022